Table 2 Characteristics between different group.
From: Association between DIAPH1 variant and posterior circulation involvement with Moyamoya disease
Variables | Group 1, with DIAPH1 variant (n = 9) | Group2, without DIAPH1 variant (n = 41) | Statistics p values |
|---|---|---|---|
Baseline data | |||
 Sex (M : F) | 6:3 | 19:22 | 0.462 |
 Age, years, median (IQR) | 35 (10–36) | 23 (9–34) | 0.245 |
History of risk factors, n (%) | |||
 Hypertension | 1 (11%) | 3 (10%) | 1.000 |
 Diabetes | 0 | 0 | 1.000 |
 Coronary heart disease | 0 | 0 | 1.000 |
 Hyperlipidemia | 0 | 0 | 1.000 |
 Smoking history | 1 (11%) | 2 (4.9%) | 1.000 |
 Alcohol taking | 0 | 0 | 1.000 |
Clinical manifestation, n (%) | 0.291 | ||
 TIA | 3 (11%) | 5 (11%) |  |
 Infarction | 3 (11%) | 22 (11%) |  |
 Hemorrhage | 3 (11%) | 14 (11%) |  |
Clinical features, mean (SD) | |||
 BMI, kg/m2 | 23.25 ± 6.13 | 22.50 ± 5.27 | 0.709 |
 PLT count, 109/L | 240.11 ± 51.84 | 263.66 ± 59.60 | 0.279 |
PCA involvement (+), n (%) | 7 (77.8%) | 5 (12.2%) | 0.001 |
Leptomeningeal (−)a (posterior to anterior), n (%) | 4 (44.5%) | 8 (19.5%) | 0.248 |
Unilateral MMD, n (%) | 0 | 2 (4.9%) | 1.000 |
Suzuki stage | |||
 Left | 0.319 | ||
 1 | 0 | 1 (2.6%) |  |
 2 | 0 | 4 (10.3%) |  |
 3 | 2 (22%) | 10 (25.6%) |  |
 4 | 3 (33%) | 10 (30%) |  |
 5 | 3 (33%) | 9 (23.1%) |  |
 6 | 1 (11%) | 5 (12.8%) |  |
 Right | 0.853 | ||
 1 | 0 | 1 (2.4%) |  |
 2 | 1 (11%) | 0 |  |
 3 | 2 (22%) | 16 (39.0%) |  |
 4 | 3 (33%) | 13 (31.7%) |  |
 5 | 3 (33%) | 8 (19.6%) |  |
 6 | 0 | 3 (7.3%) |  |
